# Mepivacaine

NDC: 51004-0005
Generic name: Mepivacaine Hydrochloride
Labeler / Manufacturer: Novocol Pharmaceutical of Canada, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: SUBMUCOSAL
Marketing started: 20150410

FDA application: ANDA088387

## Active ingredients

- MEPIVACAINE HYDROCHLORIDE: 30 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51004-0005"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51004-0005
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f58cb2c7-22a6-4341-8f9a-85c5628af797